Prenatal infection and risk for schizophrenia: IL-1β, IL-6, and TNFα inhibit cortical neuron dendrite development

Neuropsychopharmacology

Volumn 29, Issue 7, 2004, Pages 1221-1229

  Gilmore, John H ^a,b   Jarskog, Lars Fredrik ^a,b   Vadlamudi, Swarooparani ^b   Lauder, Jean M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; Cytokine; Dendrite; Development; Neuron; Schizophrenia

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL SURVIVAL; CONTROLLED STUDY; DENDRITE; INTRAUTERINE INFECTION; MEASUREMENT; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RISK FACTOR; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ANIMALS; CELL PROLIFERATION; CEREBRAL CORTEX; DENDRITES; FEMALE; INFECTION; INTERLEUKIN-1BETA; INTERLEUKIN-6; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942683385     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300446     Document Type: Article

References (106)

1. Adinolfi A (1985). The development of the human blood-CSF-brain barrier. Dev Med Child Neurol 27: 532-537.
2. Altshuler G (1993). Some placental considerations related to neurodevelopmental and other disorders. J Child Neurol 8: 78-94.
3. Araujo DM, Cotman CW (1995). Differential effects of interleukin-1b and interleukin-2 on glia and hippocampal neurons in culture. Int J Dev Neurosci 13: 201-212.
4. Bagalkote H, Pang D, Jones PB (2001). Maternal influenza and schizophrenia in offspring. Int J Ment Health 39: 3-21.
5. Banks WA, Kastin AJ, Guiterrez EG (1994). Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 179: 53-56.
6. Banks WA, Ortiz L, Plotkin SR, Kastin AJ (1991). Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259: 988-996.
7. Bartfai T, Schultzberg M (1993). Cytokines in neuronal cell types. Neurochem Int 22: 435-444.
8. Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M (2001). Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 6: 79-82.
9. Borrell J, Vela JM, Arevalo-Martin A, Molina-Holgado E, Guaza C (2002). Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26: 204-215.
10. Broadbelt K, Byne W, Jones LB (2002). Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 58: 75-81.
11. Brown AS, Begg M, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M et al (2004a). Serologic evidence for prenatal influenza in the etiology of schizophrenia. Am J Psychiatry, (in press).
12. Brown AS, Cohen P, Greenwald S, Susser E (2000b). Nonaffective psychosis after exposure to rubella. Am J Psychiatry 157: 438-443.
13. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V et al (2004b). Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Arch Gen Psychiatry, (in press).
14. Brown AS, Schaefer CA, Wyatt RJ, Goetz R, Begg M, Gorman JM et al (2000a). Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 26: 287-295.
15. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH (2001a). Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58: 1032-1037.
16. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH (2001b). Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15: 411-420.
17. Burns TM, Clough JA, Klein RM, Wood GW, Berman NEJ (1993). Developmental regulation of cytokine expression in the mouse brain. Growth Factors 9: 253-258.
18. Butler PD, Susser ES, Brown AS, Kaufman CA, Gorman JM (1994). Prenatal nutritional deprivation as a risk factor in schizophrenia: preclinical evidence. Neuropsychopharmacology 11: 227-235.
19. Cai Z, Pan Z-L, Pang Y, Evans OB, Rhodes PG (2000). Cytokine induction in fetal rat brain and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 47: 64-72.
20. Cannon M, Jones PB, Murray RM (2002). Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159: 1080-1092.
21. Carayol N, Campbell A, Vachier I, Mainprice B, Bousquet J, Godard P et al (2002). Modulation of cadherin and catenins expression by tumor necrosis factor-α and dexamethasone in human bronchial epithelial cells. Am J Respir Mol Cell Biol 26: 341-347.
22. Cervello M, Notarbartolo M, Landion M, Cusimano A, Virruso L, Montalto G et al (2001). Downregulation of wild-type β-catenin expression by interleukin 6 in hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of a cytokine. Eur J Cancer 37: 512-519.
23. Dammann O, Leviton A (1997). Maternal intrauterine infection, cytokines, and brain damage in the premature infant. Pediatr Res 42: 1-8.
24. Deguchi K, Mizuguchi M, Takashima S (1996). Immunohistochemical expression of tumor necrosis factor-α in neonatal leukomalacia. Pediatr Neurol 14: 13-16.
25. Duggan PJ, Maalouf EF, Watts TL, Sullivan MHF, Counsell SJ, Allsop J et al (2001). Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 358: 1699-1700.
26. Dziegielewska KM, Moller JE, Potter AM, EK J, Lane MA, Sanders NR (2000). Acute-phase cytokines IL-1β and TNF-α in brain development. Cell Tissue Res 299: 335-345.
27. Eklind S, Mallard C, Leverin AL, Gilland E, Mattsby-Baltzer I, Hagberg H (2001). Bacterial endotoxin sensitizes the immature brain to hypoxic-ischemic injury. Eur J Neurosci 13: 1101-1106.
28. Fatemi SH, Emamian ES, Kist DA, Sidwell RW, Nakajima K, Akhter P et al (1999). Defective corticogenesis and reduction in reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 4: 145-154.
29. Fatemi SH, Emamian ES, Sidwell RW, Kist DA, Stary JM, Earle JA et al (2002). Human influenza virus infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7: 633-640.
30. Fidel Jr PL, Romero R, Wolf N, Outright J, Ramirez M, Araneda H et al (1994). Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 170: 1467-1475.
31. Fortunato SJ, Menon RP, Swan KF, Menon R (1996). Inflammatory cytokines (interleukins 1,6,8 and tumor necrosis factor-α) release from cultured fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid. Am J Obstet Gynecol 174: 1855-1862.
32. Gadient RA, Otten U (1994). Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 637: 10-14.
33. Gelbard HA, Dzenko KA, DiLoreto D, del Cerro C, del Cerro M, Epstein LG (1993). Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 15: 417-422.
34. Gilman CP, Mattson MP (2002). Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromol Med 2: 197-214.
35. Gilmore JH, Jarskog LF (1997). Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 24: 365-367.
36. Gilmore JH, Jarskog LF, Vadlamudi S (2003). Maternal infection alters BDNF and NGF expression in the fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 138: 49-55.
37. Glantz LA, Lewis DA (1997). Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Gen Psychiatry 54: 943-952.
38. Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57: 65-73.
39. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM (1998). The fetal inflammatory syndrome. Am J Obstet Gynecol 179: 194-202.
40. Grether JK, Nelson KB (1997). Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 278: 207-211.
41. Grow J, Parks JD (2002). Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts. Clin Perinatol 29: 585-602.
42. Guiterrez EG, Banks WA, Kastin AJ (1993). Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 47: 169-176.
43. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA (1993). The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Am J Obstet Gynecol 81: 941-948.
44. Hopkins SJ, Rothwell NJ (1995). Cytokines and the nervous system I: expression and recognition. Trends Neurosci 18: 83-88.
45. Hu BR, Liu CL, Ouyang Y, Blomgren K, Siesjo BK (2000). Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20: 1294-1300.
46. Hu S, Peterson PK, Chao CC (1997). Cytokine-mediated neuronal apoptosis. Neurochem Int 30: 427-431.
47. Ivins KJ, Bui ETN, Cotman CW (1998). Amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol Dis 5: 365-378.
48. Jarskog LF, Gilmore JH (2000). Developmental expression of Bcl-2 protein in human cortex. Dev Brain Res 119: 225-230.
49. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH (2004). Apoptotic proteins in temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry 161: 109-115.
50. Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH (1997). Cytokine regulation of embryonic dopaminergic and serotonergic neuron survival in vitro. Int J Dev Neurosci 15: 711-716.
51. Jeohn GH, Kong LY, Wilson B, Hong J (1998). Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85: 1-10.
52. Jun T-Y, Pae C-U, Chae J-H, Bahk W-M, Kim K-S, Han H et al (2003). TNFβ polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res 61: 39-45.
53. Kadhim H, Tabarki B, De Prez C, Sebrire G (2001). Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol 105: 209-216.
54. Katila H, Hanninen K, Hurme M (1999). Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4: 179-181.
55. Kim I-J, Beck HN, Lein PJ, Higgins D (2002). Interferon γ induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 22: 4530-4539.
56. Koenig JI, Kirkpatrick B, Lee P (2002). Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27: 309-318.
57. Kubicki M, Westin C-F, Maier SE, Frumin M, Nestor PG, Salisbury DF et al (2002). Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry 159: 813-820.
58. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB (1994). Maternal rescue of transforming growth factor-β1 null mice. Science 264: 36-38.
59. Li Y, Ohls RK, Rosa C, Shah M, Richards DS, Christensen RD (1995). Maternal and umbilical serum concentrations of granulocyte colony-stimulating factor and its messenger RNA during clinical chorioamnionitis. Obstet Gynecol 86: 428-432.
60. Marx CE, Jarskog LF, Lauder JM, Lieberman JA, Gilmore JH (2001). Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 50: 743-749.
61. McDuffie RS, Dabies JK, Leslie KK, Sherman MP, Gibbs RS (2001). A randomized control trial of interleuklin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy. Infect Dis Obstet Gynecol 9: 233-237.
62. McGrath J, Murray R (2003). Risk factors for schizophrenia: from conception to birth. In Hirsh SR, Weinberger DR (eds). Schizophrenia. Blackwell Science: Malden, MA. pp 232-250.
63. Medlock ES, Kaplan DL, Cecchini M, Ulich TR, del Castillo J, Andresen J (1993). Granulocyte-stimulating factor crosses the placenta and stimulates fetal granulopoiesis. Blood 81: 916-922.
64. Mehler MF, Kessler JA (1994). Growth factor regulation of neuronal development. Dev Neurosci 16: 180-195.
65. Mehler MF, Kessler JA (1997). Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 20: 357-365.
66. Meira-Lima IV, Pereira AC, Mota GF, Floriano M, Araujo F, Mansur AJ et al (2003). Analysis of a polymorphism of the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia. Mol Psychiatry 8: 718-720.
67. Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leinsinger G et al (2001). Association of an IL-1β genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 158: 1316-1319.
68. Menon R, Swan KF, Lyden TW, Rote NS, Fortunato SJ (1995). Expression of inflammatory cytokines (interleukin-1β and interleukin-6) in amniochorionic membranes. Am J Obstet Gynecol 172: 493-500.
69. Merrill JE (1992). Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14: 1-10.
70. Meyer TA, Wang JJ, Tiao GM, Ogle CK, Fischer JE, Hasselgren PO (1997). Sepsis and endotoxemia in mice stimulate the expression of interleukin-1 and interleukin-6 in the central nervous system. Clin Sci 92: 519-525.
71. Mousa A, Seiger A, Kjaeldgaard A, Bakhiet M (1999). Human first trimester forebrain cells express genes for inflammatory and anti-inflammatory cytokines. Cytokine 11: 55-60.
72. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Beutler B et al (1989). Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 115: 208-213.
73. Nelson KB, Dambrosia JM, Grether JK, Phillips TM (1998). Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 44: 665-675.
74. Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde Y-A (2002). Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a Rho-dependent mechanism. J Neurosci 22: 854-862.
75. Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR et al (1998). Exposure to acute stress induces brain interleukin-1β protein in the rat. J Neurosci 18: 2239-2246.
76. O'Callaghan E, Sham PC, Talei N, Murray G, Glover G, Murray RM (1994). The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry 165: 353-356.
77. Ona VO, Li M, Vonsattel JPG, Andrews LJ, Khan SQ, Chung WM et al (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399: 263-267.
78. Pousset F (1994). Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev Brain Res 81: 143-146.
79. Ramilo O, Mustafa MM, Porter J, Saez-Llorens X, Mertsola J, Olsen KD et al (1990). Detection of interleukin 1 beta but not tumor necrosis factor-alpha in cerebrospinal fluid of children with aseptic meningitis. Am J Dis Child 144: 349-352.
80. Rivkin P, Kraut M, Barta P, Anthony J, Arria AM, Pearlson G (2000). White matter hyperintensity volume in late-onset and early-onset schizophrenia. Int J Geriatr Psychiatry 15: 1085-1089.
81. Rothwell NJ, Hopkins SJ (1995). Cytokines and the nervous system II: actions and mechanisms of actions. Trends Neurosci 18: 130-136.
82. Selemon LD, Mrzljak J, Kleinman JE, Herman MM, Goldman-Rakic PS (2003). Regional specificity in the neuropathologic substrates of schizophrenia. Arch Gen Psychiatry 60: 69-77.
83. Shi L, Fatemi SH, Sidewell RW, Patterson PH (2003). Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23: 297-302.
84. Sigmundsson T, Suckling J, Maier M, Williams SCR, Bullmore ET, Greenwood KE et al (2001). Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenia in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 158: 234-243.
85. Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J (1997). Cytokines and perinatal brain injury. Neurochem Int 30: 375-383.
86. Stallmach T, Karolyi L (1994). Augmentation of fetal granulopoiesis with chorioamnionitis during the second trimester of gestation. Hum Pathol 25: 244-247.
87. Suvisaari J, Haukka J, Tanskanen A, Hovi T, Lonnqvist J (1999). Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 156: 1100-1102.
88. Szaflarski J, Burtrum D, Silverstein FS (1995). Cerebral hypoxiaischemia stimulates cytokine gene expression in perinatal rats. Stroke 26: 1093-1100.
89. Taniguchi T, Matsuzaki N, Kameda T, Shimoya K, Jo T, Saji F et al (1991). The enhanced production of placental interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol 165: 131-137.
90. Torrey EF, Rawlings R, Waldman IN (1988). Schizophrenic births and viral diseases in two states. Schizophr Res 1: 73-77.
91. Trejo JL, Machin C, Arahuetes RM, Rua C (1995). Influence of maternal adrenalectomy and glucocorticoid administration on the development of rat cerebral cortex. Anat Embryol 192: 89-99.
92. Upfold JB, Smith MSR (1988). Maternal hyperthermia as a cause of 'idiopathic' mental retardation. Med Hypotheses 27: 89-92.
93. Urakubo A, Jarskog LF, Lieberman JA, Gilmore JH (2001). Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47: 27-36.
94. Wassink TH, Crowe RR, Andreasen NC (2000). Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia. Mol Psychiatry 5: 678-682.
95. Watson CG, Kucala T, Tilleskjor C, Jacobs L (1984). Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatry 41: 85-90.
96. Wright P, Gill M, Murray RM (1993). Schizophrenia: genetics and the maternal immune response to viral infection. Am J Med Genet (Neuropsychiatr Genet) 48: 40-46.
97. Wu YW (2002). Systemic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabilities Res Rev 8: 25-29.
98. Wu YW, Colford JM (2000). Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284: 1417-1424.
99. Yakovlev AG, Ota K, Wang G, Movsesyan V, Bao WL, Yoshihara K et al (2001). Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 21: 7439-7446.
100. Yolken RH, Torrey EF (1995). Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 8: 131-145.
101. Yoon BH, Romero R, Moon J, Chaiworapongsa T, Espinoza J, Kim YM et al (2003). Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation. J Maternal-Fetal Neonatal Med 13: 32-38.
102. Yoon BH, Romero R, Park JS, Kim JC, Kim YM, Choi J-H et al (2000). Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 182: 675-681.
103. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH et al (1996). Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174: 1433-1440.
104. Yu X, Malenka RC (2003). Catenin is critical for dendritic morphogenesis. Nat Neurosci 6: 1169-1177.
105. Zuckerman L, Rehavi M, Weiner I (2003). Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 25: 1778-1789.
106. Zuckerman L, Weiner I (2003). Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology 169: 308-313.